Feeling overall good and hit 224lbs this am! Don’t miss a day! Fire at will 🔥

Sprays going live around noon today (guessing Texan time- since I don’t remember off my head what time zone that’s called again and it’s more fitting). Might need more dihexa… 😬

Another fucking reason for them to delay GTA 6. Not falling for it.

FLGR-242 has likely been the most controversial compound introduced into the grey market, at least in the time I’ve been on X. For better or worse, it has drawn massive attention, interest, and quite literally an army of people hoping it fails, mostly for four main reasons: -Disdain for Jay Campbell. -How it was promoted on social media by BLL affiliates or general fans of the brand. -The belief that if there had been any real progress on myostatin inhibition, every pro bodybuilder would already be using it-or Big Pharma would have moved on it. -The price. It’s subjective based on individual needs, and with sales plus the ability to split vials (also with the former Slim-Assist product), most people spent far less than the advertised figures. On the first point, Jay and his team behind the scenes have been nothing but helpful and mentoring to me. Honestly, every vendor I represent-from Elite to Plugs to BLL-has had the man at the top help me in my journey more than I can describe. Everyone should be rooting for effective myostatin inhibition to become a reality, while also understanding the legitimate concerns that come with it, just like with most other compounds used in this space. If this approach is ever refined, the core idea remains: when used carefully and monitored, it could be paired with other enhancements (AAS, HGH, testosterone) so you could potentially run lower doses of the AAS side and still achieve results that previously required higher amounts. That matters for reduced side effects overall while still supporting more anabolism. The logic is that easing the myostatin “brake” makes the job of AAS or other anabolic compounds a bit easier. Most people can agree the concept is sound. The lack of independent data on FLGR-242 itself is a completely legitimate concern-and one I understand. At the same time, it seems unlikely the team would push this far with patents and related development if they didn’t have some degree of confidence in the approach. Continuing to apply the same albumin-binding concept across additional products also suggests they see real value in the underlying technology rather than treating this as a one-off gamble. It is genuinely one of the more exciting compounds to emerge in our space. Unfortunately, it took heavy criticism on X partly because some promoters claimed it would replace steroids. I’ve never said that, never thought that, and that kind of messaging sets marketing back significantly. I’ve consistently encouraged anyone considering the cost to make sure their foundation is solid first-ideally with a testosterone base and, in my view, HGH as a strong synergistic addition to the stack. What FLGR-242 actually is, and how it fits the idea above FLGR-242 is a research-chemical product marketed as an engineered follistatin analog. BLL describe it as a fragmented/modified version of follistatin-344 (based on an activin-sparing FS I-I-type isoform) fused to an albumin-binding construct. The claimed goals are selective myostatin (GDF-8) neutralization with reduced activin binding, plus a much longer circulating half-life (advertised around 19 days) via albumin hitchhiking so that dosing can be less frequent than with unmodified follistatin. The underlying biology is real and well-established. Myostatin is a key natural brake on muscle growth; neutralizing it (or follistatin’s ability to trap it) increases muscle mass and strength in animal models and in limited primate/gene-therapy human work with related follistatin approaches. Activin-sparing designs have been studied precisely to try to retain the muscle effect while dialing down broader TGF family interference. Albumin-binding tails are a proven half-life extension strategy used in approved drugs. That said, FLGR-242 itself has no published sequence, no independent analytical characterization in the literature, and no registered human clinical trials. All performance and safety claims currently come from the sellers, affiliated anecdotes, and user reports rather than peer-reviewed data on this specific molecule. It is sold for research use only. My core framing still holds: if a selective, longer-acting myostatin brake-easer works as intended and is used alongside a solid testosterone base (and ideally HGH), it could theoretically amplify the return on other anabolic tools and let people run them more conservatively. That synergy idea is exactly why the concept is interesting to people who already optimize hormones and training. It is not a steroid replacement-nor does it need to be for it to have value. It is another potential lever on the muscle-growth pathway that, if the engineering holds up, pairs with rather than substitutes for the compounds most users already rely on. As with anything in this space, the lack of controlled human data on this exact construct means individual results, safety, and long-term effects remain uncertain. People who choose to explore it generally do so with the understanding that they are operating ahead of published evidence, with source quality, bloodwork, and fundamentals (training, nutrition, and hormonal base) mattering more than the compound itself. For those already dialed in and willing to accept the grey-market trade-offs, it remains one of the more conceptually promising new tools that has appeared in recent years. I am still a supporter, a big fan, and not only with FLGR-242, I wish success to Mid-35, and many others in the space to create new avenues that people have the option to test out. My personal experience with FLGR has been nothing short of great, and I believe is one of the closest things we the public can try out in the myostatin niche, that can give us lab rats some fun and unique progress in our journey.

Becoming a big fan of this mix, despite hating the standalone grape Welch’s one.

HGH is expensive. Don’t neuter it with crushed E2 This is actually going to a be funny point considering we all unanimously make fun of the testosterone ranges on lab work, and other markers like being concerned with creatine based EGFR, despite having a avalanche of reasons thats next to useless for 99% of lifters to even look at. But when it comes to estrogen, despite men having zero symptoms of it being a issue (for the most part), they have this mystery ceiling in their head for it on lab work, and do fuck all they can do lower it lol. A lot of people still treat E2 like the enemy that needs to be driven as low as possible, especially once they’re enhanced. The problem is that in men, estrogen actually supports the GH/IGF-1 system instead of working against it. Estradiol (the main estrogen made from testosterone) helps drive GH signaling. Research has shown for years that the ability of testosterone to raise GH and IGF-1 largely depends on it aromatizing. Block that conversion or use something that doesn’t aromatize, and the response drops. Even when you’re injecting HGH, the surrounding hormonal environment still matters for how well that HGH turns into IGF-1 and how effectively your body uses it. Guys should see their IGF-1 on a fixed HGH dose move with their E2, higher E2 (within reason) tends to support better conversion until you hit the point where sides start. Beyond the numbers, crashed estrogen just makes the whole environment worse. One of the biggest practical benefits of HGH is recovery and joint health. Tanked E2 is notorious for drying out your joints and making them ache. So while the HGH is trying to help you recover and stay durable, low estrogen is actively fighting that. You train through more pain, your volume or intensity drops, and the recovery advantage gets voided out pretty much. It also affects the broader picture. Mood, sleep quality, drive, and that overall “full” anabolic feeling. HGH works better when the rest of your hormones aren’t in a depleted state. Running high test with basically no estrogen, or stacking a bunch of low-aromatizing compounds plus aggressive AI use, is a pretty reliable way to cap what the HGH can actually do for you. None of this means you should let E2 run wild. The goal is still balance, enough to support IGF-1 conversion, joint comfort, and recovery without the high-E2 sides most guys want to avoid. But deliberately crushing it just because you’re on cycle or HGH is usually counterproductive. If your IGF-1 looks underwhelming relative to the dose you’re running, or recovery still feels off, check your E2 before you just add more HGH. A lot of the time the limiter isn’t the growth hormone, it’s the estrogen you suppressed to feel “dry” or “manly”, lol. I will say IGF-1 in itself is pretty finicky, so once a established GH dose has been running awhile, I would likely want a average of IGF-1s rather than a one-and-done result. I have been talking about HGH alot, but mainly because it’s the most interesting compound, the most complex, and has so many different ways people use it, that I'm always learning something new. It provides good engagement on X, while also drawing up new conversations, because even with this many months in I still don't think I have cracked the code on it lol.

My fate..... as a manager of both..

Totally going to ruin the bulk a few weeks in lol, but muscle will be put on. I’ll deal with the fat later. We got tons of cool compounds to handle that lol!

LFG 🔥 🎂 28 💪

LFG

At some point in life, you just gotta say fuck it...

Vesugen has been one of the more popular bioregulators lately, mostly everyone chasing the research synergy with Tada among other things. I haven’t personally run this one yet, but the effects go well beyond temporary cosmetic veins. Research in vascular models shows longer-lasting changes that can stick around for months after the protocol ends. Better control of the signals that tighten blood vessels, improved communication between vessel cells, support for cell-repair pathways, healthier renewal of the vessel lining, stronger microcirculation, and fewer markers of aging in the vascular tissue. New 3 mg enteric-coated sodium caprate capsules will be dropping soon in the Vesugen format (research use only-not for human consumption). The sodium caprate + enteric coating is meant to improve absorption in lab protocols focused on those longer-term vessel health effects.

Bi-weekly reminder 👽: Comment under this post or DM me if you want in on the private Telegram. Still active and slowly rebuilding after the mass exodus weeks back! Looking for people who will be active preferably in the mosh pit (general chat LOL) while I rebuild this new X account like a COD Prestige 😀🤘💪.

Currently utilizing 500mcg once a week of Retatrutide and benefits as spoken before, are still present.

Spinning your wheels on Retatrutide: The digestion energy tax nobody talks about We all know the main downside of GLP-1s is muscle loss if you don’t run them right. You drop weight and end up smaller but still soft and proportionally unhealthy because you never protected the tissue that actually keeps you looking and performing like a lean person. There’s another angle that hits harder in the biohacking and lifting space. Even if you’re eating enough and training hard, these compounds have a threshold. Past a certain point they start working against you no matter how clean the rest of your setup is. I was in the camp slowly raising Retatrutide specifically to chase the glucagon-driven energy expenditure piece while staying in a surplus. Appetite never dropped for me, in fact I got hungrier, so the theory was nutrient partitioning plus a higher BMR letting me eat more, stay lean, and still grow. On paper it makes sense. Reta’s glucagon activity is the part that separates it from pure GLP-1s or tirzepatide; estimates put the resting energy expenditure bump in the 150-300+ kcal/day range at higher clinical doses through increased hepatic fat oxidation and thermogenesis. What I didn’t fully account for is how much energy the body still spends just processing food. The thermic effect of food is real-roughly 10% of the calories you eat on a mixed diet, and higher when protein is high (20-30% of those calories). Slowed gastric emptying is a core GLP effect. Even when your appetite feels normal, digestion is still a behind-the-scenes energy sink. The higher I pushed the dose, the more it felt like I was spinning my gears: faster plateaus, harder breakdown, and recovery that never matched what I was used to, even on TRT, HGH, and some AAS. It was basically a GLP-induced version of overtraining. You don’t always notice it until you keep hitting energy walls and start blaming sleep, training volume, or everything else, only to realize how much your system is quietly burning just to finish digesting. Fatigue shows up dose-dependently in the trial data and community reports, and a lot of people only connect the dots after the fact. In practice, the 500 mcg-2 mg range has felt much cleaner for this use case (for pretty much the entire bro community still trying to use it in a surplus stage). Two milligrams starts pushing it for some people if you’re trying to milk the calorie-defying BMR effect. Since dropping back to 500 mcg I’m looking and feeling better despite very high calories. The mental trap is chasing the sensation of the compound “working.” Sometimes the lower dose that lets you recover and actually use the food is the one that moves the needle. GLPs (and especially the triple agonists) have a real threshold. Even if you can still eat, past a point the energy cost of slowed digestion and the overall metabolic demand starts fighting the gains you’re trying to protect, particularly when you’re already running exogenous hormones and trying to build or hold tissue. Less is often more here. Protect the muscle, feed the work, and don’t assume higher always equals better just because the mechanism looks good on paper.

Good HGH article with the IU tiers by Elevate 💪